CAS 446292-08-6
:2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione
Description:
The chemical substance known as 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione, with the CAS number 446292-08-6, is a complex organic compound characterized by its unique structural features, including an isoindole core and an oxazolidine moiety. This compound exhibits potential biological activity, often investigated for its pharmacological properties. The presence of functional groups such as ketones and morpholine suggests it may interact with biological targets, making it of interest in medicinal chemistry. Its stereochemistry, particularly the (5S) configuration, indicates specific spatial arrangements that can influence its reactivity and interaction with biological systems. The compound's solubility, stability, and reactivity are influenced by its molecular structure, which can affect its application in drug development or as a research tool. Overall, this substance represents a class of compounds that may have therapeutic potential, warranting further investigation into its biological effects and mechanisms of action.
Formula:C22H19N3O6
InChI:InChI=1S/C22H19N3O6/c26-19-13-30-10-9-23(19)14-5-7-15(8-6-14)24-11-16(31-22(24)29)12-25-20(27)17-3-1-2-4-18(17)21(25)28/h1-8,16H,9-13H2/t16-/m1/s1
InChI key:InChIKey=KUQNYAUTIWQAKY-MRXNPFEDSA-N
SMILES:O=C1C=2C(C(=O)N1C[C@H]3CN(C(=O)O3)C4=CC=C(C=C4)N5C(=O)COCC5)=CC=CC2
Synonyms:- (R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
- (S)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
- 1H-Isoindole-1,3(2H)-dione, 2-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-
- 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl]methyl]-1H-isoindole-1,3(2H)-dione
- 2-[[(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione
- 2-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-Isoindole-1,3(2H)-dione
- 2-([(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl)-1H-isoindole-1,3(2H)-dione
- 1H-Isoindole-1,3(2H)-dione,2-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-5oxazolidinyl]methyl]
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.127392-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione
CAS:Formula:C22H19N3O6Purity:97%Color and Shape:SolidMolecular weight:421.4028(S)-2-((2-Oxo-3-(4-(3-Oxomorpholino)Phenyl)Oxazolidin-5-Yl)Methyl)Isoindoline-1,3-Dione
CAS:(S)-2-((2-Oxo-3-(4-(3-Oxomorpholino)Phenyl)Oxazolidin-5-Yl)Methyl)Isoindoline-1,3-DionePurity:99%Molecular weight:421.40g/molRivaroxaban EP Impurity G (Rivaroxaban USP Related Compound G)
CAS:Formula:C22H19N3O6Color and Shape:White To Off-White SolidMolecular weight:421.412-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione
CAS:Controlled ProductFormula:C22H19N3O6Color and Shape:NeatMolecular weight:421.404-[4-[(5S)-5-Phthalimidomethyl-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone
CAS:Controlled ProductFormula:C22H19N3O6Color and Shape:NeatMolecular weight:421.40(S)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
CAS:Purity:97%Molecular weight:421.4089966(S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
CAS:<p>(S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione is a useful organic compound for research related to life sciences. The catalog number is T66263 and the CAS number is 446292-08-6.</p>Formula:C22H19N3O6Color and Shape:SolidMolecular weight:421.409









